Link-Asia International Medtech Group Ltd.'s market cap is currently HK$74.02M. The company's EPS TTM is HK$0.032; its P/E ratio is 10.31; Link-Asia International Medtech Group Ltd. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	HK$ 502.00M	HK$ 529.25M	HK$ 675.52M	HK$ 595.02M	HK$ 629.95M
Gross Profit	HK$ 136.87M	HK$ 101.40M	HK$ 144.89M	HK$ 154.71M	HK$ 135.84M
Operating Income	HK$ 11.39M	HK$ -57.07M	HK$ -65.91M	HK$ -137.08M	HK$ -147.81M
EBITDA	HK$ 40.49M	HK$ -14.06M	HK$ -4.54M	HK$ -116.52M	HK$ -99.23M
Net Income	HK$ 5.26M	HK$ -54.04M	HK$ -46.40M	HK$ -173.05M	HK$ -171.74M
Balance Sheet
Cash & Short-Term Investments	HK$ 271.57M	HK$ 252.21M	HK$ 146.80M	HK$ 167.66M	HK$ 245.12M
Total Assets	HK$ 776.42M	HK$ 659.23M	HK$ 677.98M	HK$ 657.40M	HK$ 734.84M
Total Debt	HK$ 26.75M	HK$ 51.08M	HK$ 61.20M	HK$ 70.19M	HK$ 80.16M
Net Debt	HK$ -244.82M	HK$ -201.13M	HK$ -84.37M	HK$ -97.46M	HK$ -75.92M
Total Liabilities	HK$ 287.69M	HK$ 297.22M	HK$ 311.98M	HK$ 361.47M	HK$ 323.83M
Stockholders' Equity	HK$ 486.66M	HK$ 359.86M	HK$ 365.88M	HK$ 295.46M	HK$ 411.01M
Cash Flow
Free Cash Flow	HK$ -132.09M	HK$ 99.60M	HK$ -122.55M	HK$ -45.85M	HK$ -70.36M
Operating Cash Flow	HK$ -129.29M	HK$ 107.55M	HK$ -100.45M	HK$ -15.04M	HK$ -61.15M
Investing Cash Flow	HK$ 39.98M	HK$ -547.00K	HK$ 3.31M	HK$ -96.19M	HK$ -15.94M
Financing Cash Flow	HK$ 101.84M	HK$ 2.20M	HK$ 74.19M	HK$ 35.17M	HK$ -37.63M

Currency in HKD

Link-Asia International Medtech Group Ltd. Earnings and Revenue History

Income Statement >

Link-Asia International Medtech Group Ltd. Debt to Assets

Balance Sheet >

Link-Asia International Medtech Group Ltd. Cash Flow

Cash Flow >

Link-Asia International Medtech Group Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing